We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Single Dose of J&J COVID-19 Vaccine Shows Strong Immune Response
Single Dose of J&J COVID-19 Vaccine Shows Strong Immune Response
Early trial data from Johnson & Johnson’s COVID-19 vaccine candidate AD26.COV2.S has shown that a single dose was enough to generate a strong antibody response.